|

BH-30236 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • BlossomHill Therapeutics1

Indications

  • Preleukemia1
  • Leukemia, Myeloid1
  • Refractory Acute Myeloid Leukemia1
  • Leukemia1
  • Leukemia, Myeloid, Acute1

Duarte, California1 trial

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.